12 Dec, 10:09 - Indian

SENSEX 81509.46 (-0.02)

Nifty 50 24614.55 (-0.11)

Nifty Bank 53352.15 (-0.07)

Nifty IT 45923.05 (1.26)

Nifty Midcap 100 59273.15 (-0.03)

Nifty Next 50 73151.65 (-0.19)

Nifty Pharma 22307.75 (0.02)

Nifty Smallcap 100 19633.2 (-0.12)

12 Dec, 10:09 - Global

NIKKEI 225 39888.2 (1.31)

HANG SENG 20501.14 (1.72)

S&P 6097 (-0.13)

Login/Signup

You are Here : Home > Research

06-Nov-2024

Dr Reddys Laboratories

Sales up 16.45% and NP down 15.28%

'On consolidated basis

Quarter ended September 2024 compared with Quarter ended September 2023.

Net sales (including other operating income) of Dr Reddys Laboratories has increased 16.45% to Rs 8038.2 crore.  Sales of Pharmaceutical Services segment has gone up 16.26% to Rs 1,119.00 crore (accounting for 13.48% of total sales).  Sales of Global Generics segment has gone up 17.19% to Rs 7,163.60 crore (accounting for 86.30% of total sales).  Sales of Others segment has gone down 73.79% to Rs 17.90 crore (accounting for 0.22% of total sales).  Inter-segment sales rose Rs 241.20 crore to Rs 262.30 crore.  

Profit before interest, tax and other unallocable items (PBIT) has jumped 18.32% to Rs 4,777.20 crore.  PBIT of Pharmaceutical Services segment rose 100.08% to Rs 252.10 crore (accounting for 5.28% of total PBIT).  PBIT of Global Generics segment rose 16.18% to Rs 4,516.20 crore (acco...



Pleaselogin & subscribe to view the full report.

More Reports
More Reports View Company Information